Please wait ...

Phil Wolfson, MD


Phil Wolfson, MD, is Principal Investigator for a Phase 2, FDA approved 18-person study of MDMA Assisted Psychotherapy for individuals with significant anxiety due to life threatening illnesses. His clinical practice with ketamine has informed his leadership role in the development of Ketamine Assisted Psychotherapy. Phil’s book The Ketamine Papers has been published by MAPS and is the seminal work in the burgeoning ketamine arena. Phil is a sixties activist, psychiatrist/psychotherapist, writer, practicing Buddhist and psychonaut who has lived in the Bay Area for 38 years. He is the author of Noe – A Father/Son Song of Love, Life, Illness and Death (2011, North Atlantic Books). In the 1980s, he participated in clinical research with MDMA (Ecstasy). He has been awarded five patents for unique herbal medicines. He is a journalist and author of numerous articles on politics, transformation, psychedelics, consciousness and spirit, and was a founding member of the Heffter Research Institute. Phil has taught in the graduate psychology programs at JFK University, CIIS and the UCSF School of Medicine Department of Psychiatry.

 

Speaker Disclosures:
Financial: Philip Wolfson is the founder and CEO of The Ketamine Research Foundation. He has an ownership interest in Progressive Therapeutics, Inc. Dr. Wolfson will address off-label uses.
Non-financial: Philip Wolfson has no relevant non-financial relationship to disclose.

 

The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and Other Mental Distress


Faculty:
Michael Mithoefer, MD |  Bessel van der Kolk, M.D. |  Richard C. Schwartz, Ph.D. |  William Richards, Ph.D. |  Daniel McQueen, MA |  James W. Hopper, Ph.D. |  Anne St. Goar, MD |  Elizabeth Call, Psy.D. |  ....
Duration:
6 Hours 28 Minutes
Format:
Audio and Video
Copyright:
May 29, 2019
Product Code:
POS052628
Media Type:
Digital Seminar - Also available: DVD
Price:
$127.59 - Anniversary 42% off sale (42% off) Standard - $219.99

The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and other Mental Distress


Faculty:
Michael Mithoefer, MD |  Rick Doblin, Ph.D. |  Phil Wolfson, MD |  Sue Carter, PhD |  Robin Carhart-Harris, PhD |  Andrew Penn, RN, MS, NP, CNS, APRN-BC |  Richard C. Schwartz, Ph.D. |  Anne Wagner, PhD, C Psych |  ....
Duration:
3 Hours 59 Minutes
Copyright:
May 18, 2021
Product Code:
POS052719
Media Type:
Digital Seminar
Price:
$104.39 - Anniversary 42% off sale (42% off) Standard - $179.99

Showing 1 to 2 of 2 entries